{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T11:53:42Z","timestamp":1789473222360,"version":"build-2803163510"},"reference-count":98,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,7,29]],"date-time":"2020-07-29T00:00:00Z","timestamp":1595980800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Bioeng. Biotechnol."],"DOI":"10.3389\/fbioe.2020.00880","type":"journal-article","created":{"date-parts":[[2020,7,29]],"date-time":"2020-07-29T05:12:57Z","timestamp":1595999577000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":101,"title":["Drug Delivery System in the Treatment of Diabetes Mellitus"],"prefix":"10.3389","volume":"8","author":[{"given":"Ruichen","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiguo","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,7,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3390\/biom9070286","article-title":"The role of protein tyrosine phosphatase (PTP)-1B in cardiovascular disease and its interplay with insulin resistance.","volume":"9","author":"Abdelsalam","year":"2019","journal-title":"Biomolecules"},{"key":"B2","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.molmet.2016.01.002","article-title":"Integration of ATAC-seq and RNA-seq identifies human alpha cell and beta cell signature genes.","volume":"5","author":"Ackermann","year":"2016","journal-title":"Mol. Metab."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6750-12-64","article-title":"Evaluation of insulin expression and secretion in genetically engineered gut K and L-cells.","volume":"12","author":"Ahmad","year":"2012","journal-title":"BMC Biotechnol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/(sici)1096-9136(199807)15:7<539::aid-dia668>3.0.co;2-s","article-title":"Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation.","volume":"15","author":"Alberti","year":"1998","journal-title":"Diabet Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/nm.3828","article-title":"Inhibition of the glucose transporter SGLT2 with dapagliflozin in pancreatic alpha cells triggers glucagon secretion.","volume":"21","author":"Bonner","year":"2015","journal-title":"Nat. Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/j.1463-1326.2011.01440.x","article-title":"Transcriptional regulation of \u03b1-cell differentiation.","volume":"13","author":"Bramswig","year":"2011","journal-title":"Diabetes Obes. Metab."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1038\/4641132a","article-title":"Diabetes forum: extreme makeover of pancreatic alpha-cells.","volume":"464","author":"Bramswig","year":"2010","journal-title":"Nature"},{"key":"B8","doi-asserted-by":"publisher","first-page":"3246","DOI":"10.2337\/db06-0328","article-title":"Expression of IGF-I in pancreatic islets prevents lymphocytic infiltration and protects mice from type 1 diabetes.","volume":"55","author":"Casellas","year":"2006","journal-title":"Diabetes Metab. Res. Rev."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1152\/physrev.00020.2012","article-title":"11\u03b2 -hydroxysteroid dehydrogenases: intracellular gate-keepers of tissue glucocorticoid action.","volume":"93","author":"Chapman","year":"2013","journal-title":"Physiol. Rev."},{"key":"B10","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.molmet.2017.06.019","article-title":"Human beta cell mass and function in diabetes: recent advances in knowledge and technologies to understand disease pathogenesis.","volume":"6","author":"Chen","year":"2017","journal-title":"Mol. Metab."},{"key":"B11","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.pnsc.2019.10.003","article-title":"Cationic polymeric nanoformulation: recent advances in material design for CRISPR\/Cas9 gene therapy.","volume":"29","author":"Chen","year":"2019","journal-title":"Prog. Nat. Sci."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1021\/acs.accounts.9b00079","article-title":"Bioinspired and biomimetic nanomedicines.","volume":"52","author":"Chen","year":"2019","journal-title":"Acc. Chem. Res."},{"key":"B13","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0140-6736(09)62124-3","article-title":"Diabetic retinopathy.","volume":"376","author":"Cheung","year":"2010","journal-title":"Lancet"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-019-0452-8","article-title":"Lecithin nano-liposomal particle as a CRISPR\/Cas9 complex delivery system for treating type 2 diabetes.","volume":"17","author":"Cho","year":"2019","journal-title":"J. Nanobiotechnol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1021\/ml4000673","article-title":"Discovery of TUG-770: a highly potent free fatty acid receptor 1 (FFA1\/GPR40) agonist for treatment of type 2 diabetes.","volume":"4","author":"Christiansen","year":"2013","journal-title":"ACS Med. Chem. Lett."},{"key":"B16","doi-asserted-by":"publisher","first-page":"314","DOI":"10.5603\/EP.2016.0044","article-title":"Insulin therapy - new directions of research.","volume":"67","author":"Cichocka","year":"2016","journal-title":"Endokrynol. Pol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.2337\/db15-1418","article-title":"Antigen-encoding bone marrow terminates islet-directed memory CD8+ T-cell responses to alleviate islet transplant rejection.","volume":"65","author":"Coleman","year":"2016","journal-title":"Diabetes Metab. Res. Rev."},{"key":"B18","doi-asserted-by":"publisher","first-page":"241","DOI":"10.2147\/DMSO.S43731","article-title":"AMPK activation: a therapeutic target for type 2 diabetes?","volume":"7","author":"Coughlan","year":"2014","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"B19","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1080\/13543784.2019.1592156","article-title":"Using DPP-4 inhibitors to modulate beta cell function in type 1 diabetes and in the treatment of diabetic kidney disease.","volume":"28","author":"Davis","year":"2019","journal-title":"Expert Opin. Investig. Drugs"},{"key":"B20","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1021\/nl0347334","article-title":"Probing the cytotoxicity of semiconductor quantum dots.","volume":"4","author":"Derfus","year":"2004","journal-title":"Nano Lett."},{"key":"B21","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1097\/JIM.0000000000000227","article-title":"Immune interventions to preserve \u03b2 cell function in type 1 diabetes.","volume":"64","author":"Ehlers","year":"2016","journal-title":"J. Investig. Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1007\/s12325-016-0418-2","article-title":"Switching from biphasic human insulin to premix insulin analogs: a review of the evidence regarding quality of life and adherence to medication in type 2 diabetes mellitus.","volume":"33","author":"El Naggar","year":"2017","journal-title":"Adv. Ther."},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics11110597","article-title":"Review of advanced hydrogel-based cell encapsulation systems for insulin delivery in type 1 diabetes mellitus.","volume":"11","author":"Espona-Noguera","year":"2019","journal-title":"Pharmaceutics"},{"key":"B24","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.addr.2003.10.015","article-title":"The lectin-cell interaction and its implications to intestinal lectin-mediated drug delivery.","volume":"56","author":"Gabor","year":"2004","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B25","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.molcel.2017.05.032","article-title":"AMPK: mechanisms of cellular energy sensing and restoration of metabolic balance.","volume":"66","author":"Garcia","year":"2017","journal-title":"Mol. Cell."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3070","article-title":"Glucagon-like peptide-1 receptor agonists in type 2 diabetes treatment: are they all the same?","volume":"35","author":"Gentilella","year":"2019","journal-title":"Diabetes Metab. Res. Rev."},{"key":"B27","doi-asserted-by":"publisher","first-page":"4194","DOI":"10.1021\/nn400630x","article-title":"Injectable nano-network for glucose-mediated insulin delivery.","volume":"7","author":"Gu","year":"","journal-title":"ACS Nano"},{"key":"B28","doi-asserted-by":"publisher","first-page":"6758","DOI":"10.1021\/nn401617u","article-title":"Glucose-responsive microgels integrated with enzyme nanocapsules for closed-loop insulin delivery.","volume":"7","author":"Gu","year":"","journal-title":"ACS Nano"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2019.116636","article-title":"CRISPR-Cas9 system: a new-fangled dawn in gene editing.","volume":"232","author":"Gupta","year":"2019","journal-title":"Life Sci."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1463-1326.2010.01305.x","article-title":"11\u03b2-Hydroxysteroid dehydrogenase type 1 inhibition in type 2 diabetes mellitus.","volume":"13","author":"Hollis","year":"2011","journal-title":"Diabetes Obes. Metab."},{"key":"B31","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nature05485","article-title":"Inflammation and metabolic disorders.","volume":"444","author":"Hotamisligil","year":"2006","journal-title":"Nature"},{"key":"B32","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.biopha.2018.09.058","article-title":"Molecular pathways associated with oxidative stress in diabetes mellitus.","volume":"108","author":"Ighodaro","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1016\/j.clinthera.2017.03.013","article-title":"Treatment strategy for type 2 diabetes with obesity: focus on glucagon-like peptide-1 receptor agonists.","volume":"39","author":"Ji","year":"2017","journal-title":"Clin. Ther."},{"key":"B34","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1038\/nrd895","article-title":"Protein tyrosine phosphatase 1B inhibitors for diabetes.","volume":"1","author":"Johnson","year":"2002","journal-title":"Nat. Rev. Drug Discov."},{"key":"B35","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1007\/s12016-016-8587-y","article-title":"Neutralization versus reinforcement of proinflammatory cytokines to arrest autoimmunity in type 1 diabetes.","volume":"52","author":"Kaminitz","year":"2017","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.16","article-title":"Type 1 diabetes mellitus.","volume":"3","author":"Katsarou","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"B37","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.diabres.2017.11.018","article-title":"Nanotechnology based approaches for anti-diabetic drugs delivery.","volume":"136","author":"Kesharwani","year":"2018","journal-title":"Diabetes Res. Clin. Pract."},{"key":"B38","doi-asserted-by":"publisher","first-page":"584","DOI":"10.2337\/db07-1414","article-title":"Increasing GLP-1-induced beta-cell proliferation by silencing the negative regulators of signaling cAMP response element modulator-alpha and DUSP14.","volume":"57","author":"Klinger","year":"2008","journal-title":"Diabetes Metab. Res. Rev."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1038\/4441022a","article-title":"Microbial ecology: human gut microbes associated with obesity.","volume":"444","author":"Ley","year":"2006","journal-title":"Nature"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9292","article-title":"The outer mucus layer hosts a distinct intestinal microbial niche.","volume":"6","author":"Li","year":"2015","journal-title":"Nat. Commun."},{"key":"B41","doi-asserted-by":"publisher","first-page":"e122","DOI":"10.1016\/j.jconrel.2015.05.206","article-title":"Glucose-responsive micelles for insulin release.","volume":"213","author":"Li","year":"2015","journal-title":"J. Control. Release"},{"key":"B42","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.molmet.2017.05.007","article-title":"AAV-mediated pancreatic overexpression of IGF-1 counteracts progression to autoimmune diabetes in mice.","volume":"6","author":"Mallol","year":"2017","journal-title":"Mol. Metab."},{"key":"B43","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.tem.2020.01.007","article-title":"Chronic diabetes complications: the need to move beyond classical concepts.","volume":"31","author":"Mauricio","year":"2020","journal-title":"Trends Endocrinol. Metab."},{"key":"B44","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1039\/c8py01160e","article-title":"Logical design and application of prodrug platforms.","volume":"10","author":"Meng","year":"2019","journal-title":"Polymer Chem."},{"key":"B45","doi-asserted-by":"publisher","first-page":"10656","DOI":"10.1002\/anie.201702493","article-title":"Insulin-from its discovery to the industrial synthesis of modern insulin analogues.","volume":"56","author":"Moroder","year":"2017","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"B46","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.molmet.2019.09.010","article-title":"Glucagon-like peptide 1 (GLP-1).","volume":"30","author":"M\u00fcller","year":"2019","journal-title":"Mol. Metab."},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3390\/molecules24030603","article-title":"Hydrogels and their applications in targeted drug delivery.","volume":"24","author":"Narayanaswamy","year":"2019","journal-title":"Molecules"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1042\/CS20171298","article-title":"SGLT2 inhibition and kidney protection.","volume":"132","author":"Nespoux","year":"2018","journal-title":"Clin. Sci."},{"key":"B49","doi-asserted-by":"publisher","first-page":"4527","DOI":"10.1042\/BCJ20160503C","article-title":"Molecular mechanisms of ROS production and oxidative stress in diabetes.","volume":"473","author":"Newsholme","year":"2016","journal-title":"Biochem. J."},{"key":"B50","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s11892-011-0223-x","article-title":"Genetics of the HLA region in the prediction of type 1 diabetes.","volume":"11","author":"Noble","year":"2011","journal-title":"Curr. Diab. Rep."},{"key":"B51","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.metabol.2015.12.007","article-title":"The evolution of diabetic ketoacidosis: an update of its etiology, pathogenesis and management.","volume":"65","author":"Nyenwe","year":"2016","journal-title":"Metabolism"},{"key":"B52","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1126\/science.1230721","article-title":"Pleiotropic actions of insulin resistance and inflammation in metabolic homeostasis.","volume":"339","author":"Odegaard","year":"2013","journal-title":"Science"},{"key":"B53","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1007\/s00125-013-2992-z","article-title":"Inducible liver-specific knockdown of protein tyrosine phosphatase 1B improves glucose and lipid homeostasis in adult mice.","volume":"56","author":"Owen","year":"2013","journal-title":"Diabetologia"},{"key":"B54","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1007\/s00125-012-2782-z","article-title":"Endoplasmic reticulum stress upregulates protein tyrosine phosphatase 1B and impairs glucose uptake in cultured myotubes.","volume":"56","author":"Panzhinskiy","year":"2013","journal-title":"Diabetologia"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0090093","article-title":"Chronic exposure to GLP-1 increases GLP-1 synthesis and release in a pancreatic alpha cell line (\u03b1-TC1): evidence of a direct effect of GLP-1 on pancreatic alpha cells.","volume":"9","author":"Piro","year":"2014","journal-title":"PLoS One"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/j.drudis.2013.09.003","article-title":"Modulating GPR40: therapeutic promise and potential in diabetes.","volume":"18","author":"Poitout","year":"2013","journal-title":"Drug Discov. Today"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.4155\/fmc-2016-0064","article-title":"Recent advances in the development of protein tyrosine phosphatase 1B inhibitors for Type 2 diabetes.","volume":"8","author":"Qian","year":"2016","journal-title":"Future Med. Chem."},{"key":"B58","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.apsb.2019.01.011","article-title":"Red blood cell membrane-camouflaged nanoparticles: a novel drug delivery system for antitumor application.","volume":"9","author":"Qing","year":"2019","journal-title":"Acta Pharm. Sin. B"},{"key":"B59","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.3109\/10717544.2014.991001","article-title":"Novel drug delivery system: an immense hope for diabetics.","volume":"23","author":"Rai","year":"2016","journal-title":"Drug Deliv."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1080\/10717544.2018.1501119","article-title":"The challenges of oral drug delivery via nanocarriers.","volume":"25","author":"Reinholz","year":"2018","journal-title":"Drug Deliv."},{"key":"B61","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.gde.2018.01.006","article-title":"Genetics of type 1 diabetes.","volume":"50","author":"Robertson","year":"2018","journal-title":"Curr. Opin. Genet. Dev."},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00253","article-title":"Phosphatidylserine-liposomes promote tolerogenic features on dendritic cells in human type 1 diabetes by apoptotic mimicry.","volume":"9","author":"Rodriguez-Fernandez","year":"2018","journal-title":"Front. Immunol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1097\/MED.0000000000000174","article-title":"Pancreatic islet cell development and regeneration.","volume":"22","author":"Romer","year":"2015","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2019.107843","article-title":"Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition.","volume":"157","author":"Saeedi","year":"2019","journal-title":"Diabetes Res. Clin. Pract."},{"key":"B65","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.jcjd.2019.01.004","article-title":"Fast-acting insulin aspart and the need for new mealtime insulin analogues in adults with type 1 and type 2 diabetes: a canadian perspective.","volume":"43","author":"Senior","year":"2019","journal-title":"Can. J. Diabetes"},{"key":"B66","doi-asserted-by":"publisher","first-page":"15430","DOI":"10.1021\/acsami.5b03555","article-title":"N-trimethyl chitosan chloride-coated PLGA nanoparticles overcoming multiple barriers to oral insulin absorption.","volume":"7","author":"Sheng","year":"2015","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"B67","doi-asserted-by":"publisher","first-page":"E1030","DOI":"10.1152\/ajpendo.00022.2013","article-title":"\u03b1-Cells are dispensable in postnatal morphogenesis and maturation of mouse pancreatic islets.","volume":"305","author":"Shiota","year":"2013","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"B68","doi-asserted-by":"publisher","first-page":"4154","DOI":"10.2174\/1381612824666181001153605","article-title":"Protective mechanisms of butyrate on inflammatory bowel disease.","volume":"24","author":"Silva","year":"2018","journal-title":"Curr. Pharm. Des."},{"key":"B69","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1124\/pr.109.002469","article-title":"Insulin-like growth factor-I regulation of immune function: a potential therapeutic target in autoimmune diseases?","volume":"62","author":"Smith","year":"2010","journal-title":"Pharmacol. Rev."},{"key":"B70","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1002\/btpr.2484","article-title":"The CRISPR\/Cas9 system: their delivery, in vivo and ex vivo applications and clinical development by startups.","volume":"33","author":"Song","year":"2017","journal-title":"Biotechnol. Prog."},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.3390\/molecules24234209","article-title":"Nanoparticle delivery systems in the treatment of diabetes complications.","volume":"24","author":"Souto","year":"2019","journal-title":"Molecules"},{"key":"B72","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.lfs.2013.11.010","article-title":"Novel GPR40 agonist AS2575959 exhibits glucose metabolism improvement and synergistic effect with sitagliptin on insulin and incretin secretion.","volume":"94","author":"Tanaka","year":"2014","journal-title":"Life Sci."},{"key":"B73","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1038\/nature08894","article-title":"Conversion of adult pancreatic alpha-cells to beta-cells after extreme beta-cell loss.","volume":"464","author":"Thorel","year":"2010","journal-title":"Nature"},{"key":"B74","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1016\/j.amjmed.2014.07.005","article-title":"Evolution of insulin: from human to analog.","volume":"127","author":"Tibaldi","year":"2014","journal-title":"Am. J. Med."},{"key":"B75","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1111\/j.1753-0407.2012.00196.x","article-title":"Restoring insulin production for type 1 diabetes.","volume":"4","author":"Tudur\u00ed","year":"2012","journal-title":"J. Diabetes"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8091332","article-title":"Sugar-lowering drugs for type 2 diabetes mellitus and metabolic syndrome-strategies for in vivo administration: part-II.","volume":"8","author":"Vieira","year":"2019","journal-title":"J. Clin. Med."},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.201801123","article-title":"Protein corona liposomes achieve efficient oral insulin delivery by overcoming mucus and epithelial barriers.","volume":"8","author":"Wang","year":"2019","journal-title":"Adv. Healthc. Mater."},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.201807446","article-title":"Assemblies of peptide-cytotoxin conjugates for tumor-homing chemotherapy.","volume":"29","author":"Wang","year":"2019","journal-title":"Adv. Functional Mat."},{"key":"B79","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s10238-018-0519-0","article-title":"Dipeptidyl peptidase-4(DPP-4) inhibitors: promising new agents for autoimmune diabetes.","volume":"18","author":"Wang","year":"2018","journal-title":"Clin. Exp. Med."},{"key":"B80","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1007\/s00125-018-4678-z","article-title":"SGLT2 inhibitors: the future for treatment of type 2 diabetes mellitus and other chronic diseases.","volume":"61","author":"Wanner","year":"2018","journal-title":"Diabetologia"},{"key":"B81","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.jconrel.2017.09.003","article-title":"Potential of insulin nanoparticle formulations for oral delivery and diabetes treatment.","volume":"264","author":"Wong","year":"2017","journal-title":"J. Control. Release"},{"key":"B82","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.ijpharm.2017.12.036","article-title":"Microparticles, microcapsules and microspheres: a review of recent developments and prospects for oral delivery of insulin.","volume":"537","author":"Wong","year":"","journal-title":"Int. J. Pharm."},{"key":"B83","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.ijpharm.2018.07.041","article-title":"Recent advancements in oral administration of insulin-loaded liposomal drug delivery systems for diabetes mellitus.","volume":"549","author":"Wong","year":"","journal-title":"Int. J. Pharm."},{"key":"B84","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1021\/bm701274p","article-title":"Wheat germ agglutinin functionalized complexation hydrogels for oral insulin delivery.","volume":"9","author":"Wood","year":"2008","journal-title":"Biomacromolecules"},{"key":"B85","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.jconrel.2017.07.045","article-title":"Bioinspired butyrate-functionalized nanovehicles for targeted oral delivery of biomacromolecular drugs.","volume":"262","author":"Wu","year":"2017","journal-title":"J. Control. Release"},{"key":"B86","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1021\/pr500825y","article-title":"Serum metabolite signatures of type 2 diabetes mellitus complications.","volume":"14","author":"Wu","year":"2015","journal-title":"J. Proteome Res."},{"key":"B87","doi-asserted-by":"publisher","first-page":"4831","DOI":"10.1021\/nn1008319","article-title":"Multifunctional hybrid nanogel for integration of optical glucose sensing and self-regulated insulin release at physiological pH.","volume":"4","author":"Wu","year":"2010","journal-title":"ACS Nano"},{"key":"B88","doi-asserted-by":"publisher","first-page":"78.e4","DOI":"10.1016\/j.stem.2017.11.020","article-title":"Endogenous reprogramming of alpha cells into beta cells, induced by viral gene therapy, reverses autoimmune diabetes.","volume":"22","author":"Xiao","year":"2018","journal-title":"Cell Stem Cell"},{"key":"B89","doi-asserted-by":"publisher","first-page":"3881","DOI":"10.3892\/mmr.2015.3809","article-title":"Interleukin-10 gene transfer into insulin-producing \u03b2 cells protects against diabetes in non-obese diabetic mice.","volume":"12","author":"Xu","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"B90","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/s41440-017-0008-y","article-title":"Hypertension with diabetes mellitus complications.","volume":"41","author":"Yamazaki","year":"2018","journal-title":"Hypertens. Res."},{"key":"B91","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.biomaterials.2018.03.050","article-title":"Facile synthesis of semi-library of low charge density cationic polyesters from poly(alkylene maleate)s for efficient local gene delivery.","volume":"178","author":"Yan","year":"2018","journal-title":"Biomaterials"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01313","article-title":"Avidity and bystander suppressive capacity of human regulatory T cells expressing de novo autoreactive T-cell receptors in type 1 diabetes.","volume":"8","author":"Yeh","year":"2017","journal-title":"Front. Immunol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/s1471-4914(02)02279-7","article-title":"Recent advances in insulin gene therapy for type 1 diabetes.","volume":"8","author":"Yoon","year":"2002","journal-title":"Trends Mol. Med."},{"key":"B94","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1021\/acs.nanolett.6b03848","article-title":"Hypoxia and H2O2 dual-sensitive vesicles for enhanced glucose-responsive insulin delivery.","volume":"17","author":"Yu","year":"2017","journal-title":"Nano Lett."},{"key":"B95","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.cmet.2009.03.012","article-title":"AMPK: an emerging drug target for diabetes and the metabolic syndrome.","volume":"9","author":"Zhang","year":"2009","journal-title":"Cell Metab."},{"key":"B96","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1021\/acsabm.8b00470","article-title":"Polymeric microneedles integrated with metformin-loaded and PDA\/LA-coated hollow mesoporous sio2 for nir-triggered transdermal delivery on diabetic rats.","volume":"1","author":"Zhang","year":"2018","journal-title":"ACS Appl. Bio Mater."},{"key":"B97","doi-asserted-by":"publisher","first-page":"708","DOI":"10.2337\/diabetes.52.3.708","article-title":"Adeno-associated virus-mediated IL-10 gene therapy inhibits diabetes recurrence in syngeneic islet cell transplantation of NOD mice.","volume":"52","author":"Zhang","year":"2003","journal-title":"Diabetes Metab. Res. Rev."},{"key":"B98","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/s41565-019-0485-z","article-title":"Enzyme-activatable polymer-drug conjugate augments tumour penetration and treatment efficacy.","volume":"14","author":"Zhou","year":"2019","journal-title":"Nat. Nanotechnol."}],"container-title":["Frontiers in Bioengineering and Biotechnology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fbioe.2020.00880\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,29]],"date-time":"2020-07-29T05:13:00Z","timestamp":1595999580000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fbioe.2020.00880\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,29]]},"references-count":98,"alternative-id":["10.3389\/fbioe.2020.00880"],"URL":"https:\/\/doi.org\/10.3389\/fbioe.2020.00880","relation":{},"ISSN":["2296-4185"],"issn-type":[{"value":"2296-4185","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,29]]},"article-number":"880"}}